ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

23,157Medicare Part D Prescriptions Filled, Including Refills

Rank: 79 out of 3593

$649K Total Retail Price of All Prescriptions

Rank: 354 out of 3593

1,213 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
11% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 1,213 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

10% of this provider’s 1,213 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

2% of this provider’s 21,424 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

17% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$28 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
AMLODIPINE BESYLATE 1,436 1,406 1 3
LISINOPRIL 1,240 1,156 2 2
LOVASTATIN 1,146 1,081 3 20
ATORVASTATIN CALCIUM 956 894 4 15
METOPROLOL TARTRATE 925 874 5 8
OMEPRAZOLE 919 846 6 5
LEVOXYL 872 812 7 111
WARFARIN SODIUM 701 677 8 18
HYDROCHLOROTHIAZIDE 649 626 9 10
ATENOLOL 632 600 10 11
PREDNISONE 521 499 11 49
LANOXIN 489 472 10 12 223
FUROSEMIDE 466 431 13 9
HYDROCODONE-ACETAMINOPHEN 455 372 S3 14 7
GLIMEPIRIDE 439 428 15 44
METFORMIN HCL 393 359 16 6
LOSARTAN POTASSIUM 365 335 17 14
K-TAB 363 340 10 18 217
TRIAMTERENE-HCTZ 353 329 19 66
PRAVASTATIN SODIUM 283 282 20 13
ALENDRONATE SODIUM 282 277 21 22
SIMVASTATIN 282 259 21 1
ZOLPIDEM TARTRATE 265 243 23 12
OXYCODONE-ACETAMINOPHEN 243 172 S2 24 93
GEMFIBROZIL 223 189 25 88
ENALAPRIL MALEATE 203 191 26 38
CIPROFLOXACIN HCL 186 175 27 52
TAMSULOSIN HCL 185 175 28 33
LANSOPRAZOLE 185 162 28 113
CEFUROXIME 179 167 30 254
GABAPENTIN 175 163 31 16
ALLOPURINOL 174 150 32 35
VENTOLIN HFA 162 138 33 80
TRAMADOL HCL 158 146 34 17
MELOXICAM 152 139 35 29
CITALOPRAM HBR 152 144 35 25
TRILIPIX 140 124 37 233
SPIRONOLACTONE 140 138 37 86
AZITHROMYCIN 130 121 39 34
TERAZOSIN HCL 130 130 39 115
METFORMIN HCL ER 129 122 41 67
FLUNISOLIDE 128 128 42 261
RANITIDINE HCL 125 115 43 27
SERTRALINE HCL 116 102 44 28
CRESTOR 114 94 45 21
CLOPIDOGREL 109 96 46 30
MORPHINE SULFATE ER 106 76 S2 47 108
DIOVAN 105 105 48 46
CARVEDILOL 104 101 49 23
CARISOPRODOL 100 57 R 50 97
ZETIA 96 95 51 110
DILTIAZEM 24HR CD 95 91 52 173
GLYBURIDE MICRONIZED 95 86 R 52 322
FLUOXETINE HCL 93 55 54 60
ISOSORBIDE MONONITRATE ER 90 90 55 61
PAROXETINE HCL 88 88 56 62
VERAPAMIL ER 83 68 57 99
DICLOFENAC SODIUM 82 78 58 74
GLYBURIDE 82 82 R 58 55
BUMETANIDE 79 76 60 148
OXYBUTYNIN CHLORIDE 77 71 61 104
BENAZEPRIL HCL 74 74 62 69
PLAVIX 71 66 63 42
ROPINIROLE HCL 67 66 64 144
FLUTICASONE PROPIONATE 67 50 64 32
AMITRIPTYLINE HCL 67 67 R 64 90
HYDRALAZINE HCL 63 63 67 107
METHOCARBAMOL 60 55 R 68 185
NIFEDIPINE ER 59 59 69 75
TRADJENTA 59 59 69 335
AMIODARONE HCL 57 41 71 269
PANTOPRAZOLE SODIUM 57 49 71 45
DOXAZOSIN MESYLATE 56 56 73 63
VENLAFAXINE HCL 55 35 74 267
PROPRANOLOL HCL 53 53 75 181
FOSINOPRIL SODIUM 52 52 76 235
GLIPIZIDE 52 52 76 40
FLOVENT HFA 52 52 76 303
AMOX TR-POTASSIUM CLAVULANATE 52 46 76 138
JANTOVEN 51 50 80 169
ESCITALOPRAM OXALATE 50 38 81 71
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 23, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.